The Precision Medicine report provides a detailed evaluation of the technological advancements in the field of precision medicine and demand for precision medicine, including the adoption of precision medicine within both developing markets and established markets. In addition, this report, focusing on precision medicine initiatives, covers market opportunities; providing strategic insights into the technologies and key drivers that are pushing the space forward, and the role of key market players; 15 leading precision medicine vendors across the market. This extensive research suite covering advances in precision medicine also contains a detailed dataset; providing forecasts for 60 countries across a number of different metrics, including the number of patients being tested for precision medicine purposes, the number of genetic tests carried out for precision medicine, the total number of precision medicine patients receiving personalised treatment, the total spend on precision medicine testing and treatment and total precision medicine revenue.
Key Takeaways & Strategic Recommendations: Analysis of a wide range of key development opportunities and major factors within the market for precision medicine in the healthcare industry, accompanied by key strategic recommendations for stakeholders.
Benchmark Industry Forecasts: Investigating lucrative growth of precision medicine market size in full; including forecasts for the total number of patients taking genetic tests for precision medicine, the total number of genetic tests carried out for precision medicine, total number of precision medicine patients receiving medical treatment options and precision medicine drugs, total spend on precision medicine test and treatment, and total precision medicine revenue. This precision medicine market growth data is split by our 8 key forecast regions and 60 countries:
North America:
Key Statistics
- $35.7bn - Market size in 2022
- $132.3bn - Market size in 2027
- 270% - 2022 to 2027 spend growth
- 2022-2027 - Forecast period
Key Features
Market Dynamics: This section of the precision medicine study features strategic analysis of the major drivers, challenges, and innovations shaping the adoption and development of precision medicine, with key factors including the following market segmentation:- COVID-19 pandemic impact on the precision medicine market
- Future strategic direction, market share and market outlook for precision medicine
- Key issues precision medicine vendors must be aware of surrounding legislation and data sharing
Key Takeaways & Strategic Recommendations: Analysis of a wide range of key development opportunities and major factors within the market for precision medicine in the healthcare industry, accompanied by key strategic recommendations for stakeholders.
Benchmark Industry Forecasts: Investigating lucrative growth of precision medicine market size in full; including forecasts for the total number of patients taking genetic tests for precision medicine, the total number of genetic tests carried out for precision medicine, total number of precision medicine patients receiving medical treatment options and precision medicine drugs, total spend on precision medicine test and treatment, and total precision medicine revenue. This precision medicine market growth data is split by our 8 key forecast regions and 60 countries:
North America:
- Canada, United States
- Argentina, Brazil, Chile, Colombia, Ecuador, Mexico, Peru, Uruguay
- Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom
- Croatia, Czech Republic, Hungary, Poland, Romania, Russia, Turkey, Ukraine
- China, Hong Kong, Japan, South Korea
- Bangladesh, India, Nepal, Pakistan
- Australia, Indonesia, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam
- Algeria, Egypt, Israel, Kenya, Kuwait, Nigeria, Qatar, Saudi Arabia, South Africa, United Arab Emirates
Competitor Leaderboard: Key player capability and capacity assessment in the healthcare sector for 15 precision medicine vendors:
- Abbott Laboratories
- Almac Group Ltd
- AstraZeneca
- Asuragen Inc
- bioMérieux SA
- Bristol-Myers Squibb
- Cepheid Inc
- GE Healthcare
- IBM
- Illumina Inc
- Laboratory Corporation of America Holdings
- Novartis
- QIAGEN
- Quest Diagnostics
Research Deliverables
- Market Trends & Forecasts PDF Report - A comprehensive analysis of the current market landscape, alongside strategic recommendations and a walk-through of the forecasts.
- Interactive Forecast Excel - Full 5-year forecasts for every available market metric provided in Excel format, with interactive 'What If' and scenario tools.
- harvest Online Data Platform - Access the very latest data in our exclusive online data platform, harvest. All the data from Excel, with frequent updates and a more user-friendly interface.
Companies Mentioned
- Abbott Laboratories
- Almac Group Ltd
- AstraZeneca
- Asuragen Inc
- bioMérieux SA
- Bristol-Myers Squibb
- Cepheid Inc
- GE Healthcare
- IBM
- Illumina Inc
- Laboratory Corporation of America Holdings
- Novartis
- QIAGEN
- Quest Diagnostics
- Thermo Fisher Scientific Inc.